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Abstract
Background: The Daming capsule (DMC) is a traditional Chinese medicine used to treat hyperlipoidemia. Both
clinic trials and studies on animal models have demonstrated that DMC is beneficial against diabetic symptoms.
Impairment of the baroreflex can cause life-threatening arrhythmias and sudden cardiac death in patients with
diabetes mellitus (DM). This study was designed to elucidate the effects of DMC on baroreflexes in streptozocin
(STZ)-induced diabetic rats with hyperlipoidemia.
Methods: Wistar rats were randomly divided into three groups: untreated controls, rats pretreated STZ and high
lipids (a diabetes model or DM rats), and DM rats treated with DMC. The baroreflex sensitivity was examined
during intravenous injection of phenylephrine (PE) or sodium nitroprusside (SNP) and quantified by the change in
heart rate over the change in mean arterial blood pressure (ΔHR/ΔMABP). Morphological remodeling of
baroreceptors was analyzed by transmission electron microscopy (TEM). The mRNA levels and expression of GluR2
and a GABAA receptor subunit were measured by quantitative RT-PCR and Western blotting.
Results: Compared to untreated DM rats, DMC significantly elevated the ratio of ΔHR/ΔMABP by enhancing the
compensatory reduction in HR (-ΔHR) in response to PE-induced hypertension (+ΔMABP) (P < 0.05). In the presence of
SNP, DMC increased the ΔMABP (P < 0.05). In addition, DMC markedly shortened the duration of blood pressure
changes elicited by PE or SNP in DM rats compared to the untreated DM group (P < 0.05). Electron microscopy
revealed disrupted myelin sheaths, swollen ER, and lysed mitochondria in the nucleus ambiguous (NAm) DM rats. These
signs of neuropathology were largely prevented by treatment with DMC for 30 days. Treatment with DMC elevated
both mRNA and protein level of GluR2 in the NAm of DM rats, but had no effect on GABAA receptor expression.
Conclusion: The Daming capsule partially reversed the parasympathetic baroreflex impairment observed in STZ-
induced diabetic rats with hyperlipoidemia. Treatment with DMC also prevented the degeneration of neurons and
myelinated axons in the brain stem NAm and reversed the down-regulation of GluR2 mRNA. Rescue of NAm
function may contribute to the medicinal properties of DMC in diabetic rats.
Background
Autonomic neuropathic dysfunctions are common com-
plications in type 2 diabetic patients [1,2]. Impairment
of baroreflexes that control heart rate (HR) under condi-
tions of changing arterial blood pressure may contribute
to life-threatening arrhythmias and sudden cardiac
death [3,4]. Drugs with protective effects on autonomic
neuropathy may reduce the mortality induced by dia-
betes mellitus (DM). Thiazolidinediones (TDs) are hypo-
glycemic agents that are widely accepted as best
treatment for the clinical management of type 2 dia-
betes. However, inconsistent outcomes limited the usage
of TDs for diabetic patients with cardiovascular disease
[5,6]. Recently, statins were shown to reduce diabetic
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18,000 diabetic patients across 14 trials revealed that dia-
betics at “sufficiently high risk” for vascular events could
benefit from statins [8-10]. These results suggest that
patients with cardiac dysfunction could profit from lipid-
modulating drugs. Nevertheless, long-term treatment
with statins could lead to rhabdomyolysis. Therefore, it is
essential to develop alternative drugs to prevent the
blunted baroreflex sensitivity induced by DM.
The Daming Capsule (DMC) is a combination of tra-
ditional Chinese herbs with a variety of medicinal prop-
erties. Our previous study indicated that DMC therapy
significantly reduced total cholesterol (TC) and low den-
sity lipoprotein (LDL) content in hyperlipoidemia
patients with few adverse side effects [11]. Further study
demonstrated that DMC could reverse the prolonged
QT and PR interval and improve cardiac function in
diabetic rats. This cardioprotective effect may be
mediated, at least partially, by modulating the mRNA
transcription and protein expression of Kv4.2 and a1c
and by preventing DM-induced dysfunction of cardiac
myocytes [12].
It is well known that cardiac function is regulated by
baroreflex circuitry and that baroreflex sensitivity is
usually impaired in patients with DM [1]. Given the
broad spectrum of potential DMC benefits, in particular
the robust cardioprotective responses, we investigated
the effects of DMC on baroreflex sensitivity in diabetic
rats with hyperlipoidemia.
Methods
Preparation of DMC
The present formulation of the DMC was designed by
the Department of Pharmacology of Harbin Medical
University and prepared by Harbin Yida Ltd. The pre-
paration of DMC was described in detail in our previous
publications [11,12]. Briefly, Rheum palmatum (Solana-
ceae) was harvested from Gansu province, China, after 3
years of cultivation. Cassia obtusifolia L. (pulse family)
and Panax ginseng C.A. (Acanthopanax gracilistylus)
were harvested from Sichuan province after a 1-year
cultivation period, and Salvia miltiorrhiza (Labiatae)
was obtained from Jilin province after an 8-year cultiva-
tion period. These plant materials were all collected
from September to November. Voucher specimens of
Rheum palmatum (1.008.1), Cassia obtusifolia L.
(6.048.1), Panax ginseng C.A. (1.058.1), and Salvia mil-
tiorrhiza (1.080.1) were deposited at the Heilongjiang
Food and Drug Administration. The samples were
ground into powder and cased in capsules in a Rheum
palmatum: Cassia obtusifolia L.: Salvia miltiorrhiza:
Panax ginseng C.A. ratio of 12:12:6:1. All processes fol-
lowed the regulations of the State Food and Drug
Administration of China.
Quality control by quantitative analysis of the total
anthraquinones
Quality control standards and quantitative analysis of
DMC were described in our previous publication [12].
Briefly, the total anthraquinone content was determined
by the marker compound chrysophanol using high per-
formance liquid chromatography (HPLC). Chromato-
graphic separation employed a ZORBAX C18 column
(250 mm × 4.6 mm, 5 μm) and a mobile phase com-
posed of methanol-1% phosphate acid solution (85:15).
The flow rate was 1.0 ml/min and anthraquinones were
detected by 254 nm absorbance. Only DMC samples
with more than 1.5 mg of chrysophanol in each 300 mg
capsule were used in the present study.
Animals
Male Wistar rats (200-230 g, n =4 0 )w e r eo b t a i n e d
from the Animal Center of the Second Affiliated Hospi-
tal of Harbin Medical University, China, and housed
under controlled temperature (23 ± 1°C) and humidity
(55 ± 5%) with a 12 h-12 h light-dark cycle. The study
received approval from the ethics committee of Harbin
Medical University (HMUIRB-2008-06).
Establishment of diabetic animal model
In accordance with our previous study [12], fat emulsion
was prepared with lard (20%), thyreostat (1%), choles-
terol (5%), sucrose (5%), fructose (5%), sodium gluta-
mate (1%) and salt (6%), and emulsified in 20% Tween
80 with 30% propylene glycol. The emulsion was stored
at 4°C until use. All rats were equally and randomly
divided into 3 groups. The control rats (Ctr) group
received 0.9% NaCl by oral administration. The diabetic
model group (DM) first received fat emulsion (10 ml/
kg) by oral administration for the first 10 days and then
were given streptozocin (STZ, in 0.1 M citrate buffer
solution, pH 4.2, Sigma) at 40 mg/kg by intraperitoneal
(i.p.) injection once daily for 3 d. Fasting blood glucose
(FBG) levels were measured 72 h after the last STZ
administration using a Grace glucometer (Grace Medi-
cal, Inc. America) to ensure induction of diabetic symp-
toms. Rats with FBG levels higher than 16.7 mmol/l or
300 mg/dl were judged to successfully model DM in
rats. These rats were then treated with the fat emulsion
(10 ml/kg) for 30 d. The FBG was tested during this
period to monitor diabetic status. The DMC-treated rats
(both controls and DM model rats fed the fat emulsion)
were given 100 mg/kg/d DMC for 30 d.
Biochemical Estimations
Blood was collected from heart, then separated and ana-
lyzed for total cholesterol (TC) and triglycerides (TG)
using appropriate kits (Nanjing Jiancheng Bioengineering
Institute, China).
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Rats were anesthetized with sodium pentobarbital (40
mg/kg) by i.p. injection. Supplemental doses of anes-
thetic (0.1 ml of 1% sodium pentobarbital) was adminis-
tered every 30 min to maintain deep sedation as
indicated by lack of eye blink and withdrawal reflexes.
For blood pressure measurements, the ends of short
polyethylene-50 tubes were tapered down to 0.5 mm to
form the insertion ends of catheters. The left femoral
artery and right femoral vein were exposed and the
tapered tips of the two catheters (both filled with hepar-
inized saline) were inserted. Vasoactive drugs were
injected into the femoral vein through one catheter and
blood pressure was monitored through the femoral
artery by connecting the catheter to a blood pressure
transducer (MlT0699, AD instruments). The transducer
was positioned at heart level.
Baroreflex sensitivity
Arterial blood pressure (ABP) was measured using the
BL-420 Data Acquisition & Analysis System (Chengdu
Tme Technology Co., Ltd. China). Mean arterial blood
pressure (MABP) and HR were then recorded automati-
cally. A series of phenylephrine (PE) injects at 16, 32,
64, 128, and 256 μg/ml was used to elevate BP. Alterna-
tively, sodium nitroprosside (SNP) at 10, 20, 40, 80, then
160 μg / m lw a su s e dt ol o w e rB P .B o t hd r u g sw e r e
injected in a fixed volume (0.04 ml/100 mg). The next
drug concentration was injected only when the HR and
ABP level had reached a plateau from the preceding
injection. The ΔHR response (maximal HR - baseline
HR) to the ΔMABP (maximal MABP - baseline MABP)
induced by injections of PE or SNP were used to con-
struct dose-response and baroreflex sensitivity curves.
For dose-response curves, ΔHR/ΔMABP was plotted as
the function of PE and SNP dose. The ΔHR to ΔMABP
relationship were also plotted to illustrate the ΔHR
changes induced by ΔMABP. All curves were fitted to
the Boltzmann equation using Prism 5.0 software
[13-19].
Transmission electron microscopy (TEM) Analysis
The location of the nucleus ambiguous (NAm) was
identified as previously described [20]. Tissue samples
were prepared by routine methods for TEM analysis. In
brief, 1.0 mm Epon embedded sections through the
NAm were stained with uranyl acetate and lead citrate
and examined by JEOL 1200 electron microscope (JEOL
Co., Japan).
Quantitative RT-PCR analysis
Total RNA was prepared from rat brain stem (±600 μm
from 0 point), and mRNA levels of alpha-amino-3-
hydroxy-5-methyl-4-isoxazole propionate (AMPA)
receptor subunit 2 (GluR2: F: TGTCCTCCTTTCT
CCCT, R: CTGAACCATCCCTACCC) and gamma ami-
nobutyric acid A receptor (GABAA)(F: CTGAAGTGAA-
GACGGACAT, R: ACGCAGGAGTTTATTGG) were
measured using the SYBR Green PCR Master Mix Kit
(Ambion, Austin, TX, USA) on a 7500 FAST Real-Time
PCR System (Applied Biosystems, Foster City, CA, USA)
with the U6 gene as an internal control (F: GCTTC
GGCAGCACATATACTAAAAT, R:CGCTTCACGAAT
TTGCGTGTC AT).
Western blot analysis
The expression of proteins in brain stem tissues (±600
μm from 0 point) was detected by Western blot analysis.
The proteins examined were GluR2 (88 kDa) and
GABAA (70 kDa). The primary antibodies and HRP-
conjugated secondary antibodies were all purchased
from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Tissues were lysed in 600 μl lysis buffer containing 1%
protease inhibitor solution, and then centrifuged at
12,000 × g for 30 min to collect the soluble protein
extracts from the supernatant. The protein concentra-
tion was determined by a Sunrise-Basic Tecan micro-
plate reader (Tecan, Austria) using bovine serum
albumin as the standard. Protein samples were resolved
on 10% SDS-PAGE gels and transferred to PVDF mem-
branes (Bio-Rad, Hercules, CA, USA). The PVDF mem-
branes were then incubated with the indicated primary
antibodies diluted at 1:3,000 in PBS buffer for 1 h at
room temperature. Inhibitory peptides were used in
some trials to confirm antibody specificity. After wash-
ing three times in PBS-T (10 min each wash), the PVDF
membranes were incubated for 1 h at room temperature
with HRP-conjugated secondary antibodies (1:5,000) in
PBS-T blocking buffer containing 5% dry milk. Protein
bands were then detected with the Odyssey infrared
imaging system (LI-COR, Lincolin, NB, USA). An anti-
body to b-actin at 1:10,000 was used as the loading con-
trol. The SDS-PAGE gels were stained with Coomassie
blue solution before the electrotransfer of proteins to
verify the quantity of the protein recovered and the
quality of separation. Densitometry analysis was per-
formed with Quantity One software (Area × OD), and
the density of each protein was normalized to b-actin.
The normalized expression levels of target proteins are
p r e s e n t e da sf o l dc h a n g e so v e rt h ee x p r e s s i o no ft h e
control samples.
Statistical analysis
Data are presented as means ± S.E.M. Statistical com-
parison of baseline MABP and HR between groups was
determined using Student’st - t e s t s .T oc o m p a r et h e
dose-response curves between treatment groups,
one-way ANOVA with repeated measures were used.
Ai et al. BMC Complementary and Alternative Medicine 2010, 10:80
http://www.biomedcentral.com/1472-6882/10/80
Page 3 of 9P < 0.05 was considered statistical significant. All curves
were plotted using Graphpad Prism 5.0 software.
Results
Biochemical Estimations
In rats administered with STZ and then fed the high-fat
emulsion for 30 days, fasting blood glucose (FBG), tri-
glycerides (TG), and total cholesterol (TC) were all sig-
nificantly elevated (Figure 1), indicating that diabetic
and hyperlipoidemia symptoms were successfully estab-
lished in the DM group. Daily treatment with DMC for
30d dramatically decreased both FBG and TC levels in
the second cohort of these lipid-fed DM rats (DM +
DMC). In contrast, no significant change in TG was
observed in DMC-treated diabetic rats compared to DM
rats (Figure 1C).
Effects of DMC on resting blood pressure and heart rate
in anaesthetized rats
After rats were anaesthetized by sodium pentobarbital,
resting MABP and HR were measured before PE or
SNP application. In control rats, MABP and HR were
119.78 ± 2.6 mmHg and 369.83 ± 5.1 beats/min and
DMC had no effect on either basal MABP or HR in
control rats (data not shown). In DM rats, MABP and
HR were reduced to 90.05 ± 2.5 mmHg and 288.67 ±
12.9 beats/min. Treatment with DMC did not signifi-
cantly alter baseline MABP and HR in DM rats (P >
0.05; Figure 2A and 2B).
Baroreflex control of HR during PE application
Gradual increases in MABP were measured in all
experimental rats following intravenous injections of
PE (Figure 3A, B and 3C). Compared with the
untreated control group, the PE-induced ΔMABP
increase was significantly suppressed in DM rats as
indicated by the rightward shift in the PE-ΔMABP
curve (Figure 3D, P < 0.05). When DM rats were trea-
ted with DMC for 30 d, however, the PE-ΔMABP
curve was shifted leftward toward the control curve
(P < 0.05). The ratio of ΔHR/ΔMABP is also an index
of parasympathetic baroreflex sensitivity and was sig-
nificantly decreased in DM rats compared to untreated
control rats. The ratios were enhanced after DMC
administration, indicating partial rescue of the barore-
ceptor reflex. For example, at a PE dose of 128 μg/ml,
ΔHR/ΔMABP was 1.74 ± 0.28 in control rats, 0.47 ±
0.12 in DM rats, and 1.02 ± 0.16 in DM+DMC rats
(Figure 3E, P < 0.05). Parasympathetic baroreflex sensi-
tivity is also described by the compensatory change in
HR (ΔHR) as a function of the change in blood pres-
sure (ΔMABP) during physiological or pharmacological
perturbations (e.g. PE injections) [19]. Figure 3F illus-
trates that DMC significantly increased the -ΔHR
response in PE-injected DM rats. Indeed, the relation
between ΔHR to ΔMABP was virtually flat in DM rats,
indicating near total suppression of the baroreceptor
reflex. In the DM+DMC group, however, a ΔMABP
greater than 30-40 mmHg was associated with a
Figure 1 Effects of DMC on FBG, TG and TC in diabetic rats. FBG: fasting blood glucose; TG: triglycerides; TC: total cholesterol. n = 10.
Figure 2 Resting mean arterial blood pressure (MABP) and
heart rate (HR) in control, DM model rats, and DM rats treated
with DMC. Data are presented as Mean ± S.E.M. * mean value was
significantly different from that of the control group (P < 0.05). n =
10.
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reflex. No effect of DMC on the ΔHR to ΔMABP of
untreated control rats was observed (data not shown, P
> 0.05).
Baroreflex control of HR during SNP application
The baroreflex response mediates both a decrease in HR
during rising MABP and an increase in HR in response
to reduced MABP (Figure 4A, B and 4C). Decreases in
ΔMABP induced by different SNP dosages were signifi-
cantly attenuated in DM rats as indicated by the right-
ward shift in the SNP-ΔMABP curve. Again, the
SNP-ΔMABP relation was partially reversed by DMC
treatment (P< 0.05). The SNP dose-dependent curves for
sympathetic baroreflex sensitivity (ΔHR/ΔMABP versus
SNP) and ΔHR versus ΔMABP were plotted (Figure 4E,
F) but showed no differences between control, DM, and
DM + DMC groups (Figure 4E, P > 0.05). However,
DMC treatment did markedly elevate the SNP-induced
ΔMABP level in DM rats (Figure 4D, F and Table 1). For
example, at 160 μg/ml, the maximum ΔMABP was 57.02
mmHg in control rats, 24.33 mmHg in DM rats and
38.87 mmHg in DM +DMC rats. The sympathetic baror-
eflex sensitivity was not changed in control rats after
administrated with DMC (data not shown, P > 0.05)
DMC shortened the ABP recovery time after PE or SNP
application in DM rats
T h er e c o v e r yt i m eo fa r t e r i a lB Pc h a n g e sf o l l o w i n gP E
or SNP injection is another key index used to evaluate
baroreflex sensitivity [21]. Our results demonstrated that
the time of recovery to baseline after drug treatment
w a ss i g n i f i c a n t l yl o n g e ri nD Mr a t sc o m p a r e dt o
untreated control, while DMC significant reduced the
(elongated) duration of the PE-induced and SNP-
induced ΔABP. For example, at a PE dose of 128 μg/ml,
the duration to recovery from peak ABP to baseline was
76.83 ± 18.2 s in control rats, 139.3 ± 25.3 s in DM rats,
and 88.2 ± 18.8 s in DM + DMC rats (Figure 5A, P <
0.05). Similarly, when the SNP dose was 80 μg/ml, the
durations to recovery were 60.2 ± 10.1 s, 134.8 ± 19.3 s,
and 73.83 ± 11.6 s (Figure 5B, P < 0.05). Thus, DMC
did improve the biphasic baroreceptor response, at least
using drug sensitivity and recovery time as indices.
DMC reversed the ultrastructure remodeled in NA of DM
rats
Transmission electron micrographs revealed swelling of
the endoplasmic reticulum and mitochondria, as well as
damage to the Golgi body complex in NAm neurons of
DM rats (Figure 6A and 6B). Again, treatment with
Figure 3 Effect of DMC on the attenuation of baroreflex sensitivity in DM rats following PE administration. A: Normal rat (Ctr). B: DM rat
(DM). C: DMC-treated DM model rat (DMC). Trace: blood pressure changes induced by PE application at 16, 64, and 128 μg/ml. D) Dose
dependent ΔMABP curve of rats; E) Dose dependent Δ HR/Δ MABP curve of rats; F) Correlation of Δ HR to Δ MABP in rats at different PE
dosages. n =8 .
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(Figure 6C). In DM rats, the myelin surrounding NAm
axons was often damaged and axons were of smaller
diameter from cytoplasmic shrinkage, leading to voids
between the myelin and axolemma (Figure 6E). These
morphological signs of nerve damage, however, were
not observed in DMC-treated rats (Figure 4F).
DMC significantly elevated mRNA and protein expression
of GluR2 of DM rats
Finally, we examined the expression of AMPA-type
GluR2 and GABAA receptors, as these are the major
excitatory and inhibitor transmitters that mediate signal
transduction between baroreceptors and the brain stem
NAm. The DM rats demonstrated significant down reg-
ulation of GluR2 and GABAA receptor subunit mRNA
and protein (Figure 7). Both the down-regulation in
GluR2 mRNA and protein were reversed by DMC treat-
ment in DM rats (Figure 7A and 7C, P < 0.05). In con-
trast, DMC did not restore mRNA levels or expression
of GABAA receptors in DM rats (Figure 7B and 7D, P >
0.05).
Discussion
The Daming pill (DMC) was designed from several Chi-
nese herbs and possesses a multitude of medicinal
effects. Indeed, our previous study demonstrated that
DMC was cardioprotective in DM rats by improving
both diastolic and systolic functions of the heart and by
protecting individual cardiac myocytes against DM-asso-
ciated morphological rearrangements [12]. The present
study underscores and extends the cardioprotective
Figure 4 Effect of DMC on the attenuation of baroreflex sensitivity in DM rats following SNP administration. A: Normal rat(Ctr). B: DM rat
(DM). C: DMC-treated DM rat (DMC). Trace: blood pressure changes induced by SNP application at 10, 40, and 80 μg/ml. D) Dose dependent Δ
MABP curve of rats; E) Dose dependent Δ HR/Δ MABP curve of rats; F) Correlation of Δ HR to Δ MABP in rats at different PE doses. n =8 .
Table 1 Arterial blood pressure and HR before and after PE and/or SNP administration
Baseline PE (256 μg/ml) SNP(160 μg/ml) HR range
Ctr MABP(mmHg) 119.78 ± 2.61 162.78 ± 3.64* 62.76 ± 3.24*
HR (mmHg) 369.83 ± 5.04 293.13 ± 5.52* 374.99 ± 6.21 81.86 ± 4.27
DM MABP (mmHg) 90.05 ± 2.47
# 127.17 ± 4.25* 66.62 ± 4.56*
HR (beats/min) 288.67 ± 8.84
# 272.17 ± 6.26 293.07 ± 7.36 20.90 ± 4.05
DMC MABP (mmHg) 91.93 ± 1.14
# 130.61 ± 4.25* 53.4 ± 4.62*
HR (mmHg) 287.5 ± 6.31
# 241.2 ± 5.36* 292.29 ± 3.47 51.09 ± 5.17
Ctr: control group; DM: diabetic mellitus; DMC: Daming capsule; MABP: Mean arterial blood pressure; HR: heart rate; PE: phenylephrine; SNP: sodium nitroprusside.
Data are presented as Mean ± S.E.M.
# Mean value was significantly different from that of the control group (P < 0.05). *Mean value was significantly different
from that of the baseline (P < 0.05). n =8 .
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ment also improved the baroreflex sensitivity in DM
rats by increasing the sensitivity of the compensatory
ΔHR response during pharmacologically-induced
ΔMABP. In addition, DMC reduced the time required
for recovery from ΔMABP perturbations induced by PE
and SNP. Further evidence suggested that DMC pre-
served the functional integrity of baroreceptor neurons
by preventing neuronal damage in the nucleus ambigu-
ous and by restoring the expression of AMPA receptors
containing GluR2.
In the present study, we found that long-term DMC
treatment significantly improved the impaired parasym-
pathetic baroreflex gain in DM rats as indicated by both
the ΔHR versus ΔMABP relation and the time to recov-
ery following PE treatment. In DM rats, this relation
was flat (no ΔHR in response to ΔMABP), indicating
that the baroreceptor reflex was severely compromised
in DM rats. In contrast, no improvement in barorecep-
tor sensitivity was found in response to SNP application
as measured by the ΔHR versus ΔMABP relation. How-
ever, DM rats already had reduced MABP and HR, so
the dynamic range may have been reduced below the
threshold range of the rat baroreceptors. Indeed, heart
rate did not change with blood pressure changes below
30 mmHg even in healthy untreated rats. Under low
blood pressure, a compensatory increase in heart rate
may not have been efficiently signaled through the bar-
oreceptor reflex. In order to further assess the actions of
D M C ,t h er e c o v e r yt i m ef o l l o w i n gP Ea n dS N Pt r e a t -
ment were assessed. The results clearly demonstrated
that the prolonged recovery time in DM rats treated
with SNP was improved by DMC treatment, indicating
that DMC could improve some aspects of BP regulation
even when BP was reduced.
Baroreceptor sensitivity is exquisitely sensitive to cel-
lular energy charge [22] and we observed damaged
mitochondria, in addition to dilated endoplasmic
Figure 5 DMC significantly shorten the prolonged recovery
time of ABP changes induced by PE or SNP in DM rats.A )
Durations of ABP increasing level after PE (128 μg/ml) application; B)
Durations of the decreased ABP level after SNP (80 μg/ml)
application. Data are presented as Mean ± S.E.M. n =6 .
Figure 6 Electron micrographs showing the ultrastructural characteristics of NAm neurons in normal, DM, and DMC-treated DM rats.
A: Electron micrograph of cytoplasm from a NAm neuron in a normal rat. The mitochondria (indicated by a hollow arrow) and endoplasmic
reticulum (indicated by a solid arrow) are the predominant cytoplasmic organelles. B: Electron micrograph of the cytoplasm from a NAm neuron
in a DM rat. The expanded endoplasmic reticulum is circled by a dashed line ellipse, the expanded Golgi body is circled by a solid line, and the
partially lysed mitochondrion is indicated by a hollow arrow. C: Electron micrograph of the cytoplasm from a NAm neuron from a DMC-treated
DM rat showing regular mitochondrial and endoplasmic reticulum structure. D: Electron micrograph of myelinated nerves from the NAm in a
normal rat. Microtubules, microfilaments, and neurofilaments are visible in the medullary sheath and the membranes of myelinated nerves are
attached tightly to the inner wall of the medullary sheath. E: Electron micrograph of myelinated nerves from the NAm in a DM rat. Axons appear
to detach from the myelin sheath, yielding enlarged paces between the axolemma and medullary sheaths (hollow arrows). Decreased electron
density indicates partial dissolution of the axoplasm (* symbol). F: Electron micrograph of myelinated nerves from the NAm a DMC-treated DM
rat showing a reduction in the spaces between the axolemma and medullary sheaths (indicated by hollow arrow). Scale bar: 1.0 μm.
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sule effectively prevented these signs of neuropathology
in DM rats and hence preserved the function of the
brain stem. Under normal conditions, myelination
improves axonal conduction velocity by restricting cur-
rent flow to nodes and decreasing membrane capaci-
tance [23]. Abnormal myelination, including myelin
sheath atrophy or thickening, can reduce impulses pro-
pagation velocity or cause conduction failure. The result
that DMC improved the impaired baroreflex sensitivity
m a yb ee x p l a i n e d ,a tl e a s ti np a r t ,b yp r e v e n t i o no ft h e
DM-associated atrophy of NAm neurons and axons that
mediate the brain stem baroreceptor reflex. Both gluta-
mate and GABA also play important roles in maintain-
ing baroreflex sensitivity. The release of glutamate could
decrease blood pressure through the action of glutamate
on AMPA receptors containing GluR2 [24,25] while
GABA increases blood pressure by inhibiting the para-
sympathetic system circuit via GABAA receptors [26,27].
Our findings suggested that the protective effects of
DMC on baroreflex control of heart rate could be due
to the upregulation of GluR2 and a concomitant
increase in synaptic transmission or neuronal excitability
within the baroreceptor reflex pathway.
Figure 7 mRNA and protein expression levels of GluR2 and GABAA receptor. The relative mRNA levels are shown in A (GluR2) and B
(GABAA) and the relative protein levels are shown in C (GluR2) and D (GABAA). Data are presented as Mean ± S.E.M. n =6 .
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In summary, DMC prevented the parasympathetic bar-
oreflex impairment in the STZ-induced diabetic rat
model with hyperlipoidemia. The mechanisms may be
related to the elevated sensitivity of the baroreflex con-
ferred by improved neuronal function in the NAm.
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